Pinnen, F
As patients lose weight, they often report: Improved mobility and reduced joint discomfort Better sleep quality and reduced sleep apnoea symptoms Improved exercise tolerance Improved mood and psychological wellbeing Some patients may experience reduced inflammatory markers (such as C-reactive protein) as metabolic health improves
Investigated applications In the published preclinical and clinical literature, the effects of NAD+ (and its precursors) are documented in the following areas: Age-related decline of functions , robustly demonstrated in animal models Mitochondrial dysfunctions , emerging clinical data Neurodegenerative diseases (Alzheimers, Parkinsons), Phase 2 trials Chronic fatigue syndrome , observational data, IV NAD+ therapy Addiction treatment , alcohol, opioids (anecdotal, some studies) Metabolic syndrome and insulin resistance , Phase 2 data with NMN Cardiovascular function , endothelial function, blood pressure Skin aging , cosmetic research Post-COVID long-term symptoms , emerging research Sarcopenia , preclinical and Phase 2 data Buying NAD+: what to look for When buying NAD+ , the decisive criterion is not the price but the verifiability of quality
2023;152:e2023061501
In reality, methylation depends on cellular energy, mitochondrial one-carbon metabolism, amino-acid handling, redox balance and the removal of homocysteine and adenosine
Do not reduce protein below 1.2 grams per kilogram
